NCT07096778
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07096778
Title Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (DoMMino-1)
Acronym DoMMino-1
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CellCentric Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
American Oncology Partners, PA RECRUITING Bethesda Maryland 20817 United States Details
University of Nebraska Medical Center RECRUITING Omaha Nebraska 68198 United States Details
University of Pennsylvania, Abramson Cancer Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
The Christie NHS Foundation Trust RECRUITING Withington Greater Manchester M20 4BX United Kingdom Details
Royal Marsden NHS Foundation Trust RECRUITING Sutton London SM2 5PT United Kingdom Details
The Clatterbridge Cancer Centre NHS Foundation Trust RECRUITING Bebington Wirral CH63 4JY United Kingdom Details
Western General Hospital RECRUITING Edinburgh EH4 2XU United Kingdom Details
Barts Health NHS Trust RECRUITING London EC1A 7BE United Kingdom Details
King's College Hospital NHS Foundation Trust RECRUITING London SE5 9RS United Kingdom Details
Imperial College Healthcare NHS Trust, Hammersmith Hospital RECRUITING London W12 0HS United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field